As we begin a new year, the UAB Comprehensive Diabetes Center has compiled key conference and grant submission dates for 2025.

Scientists at the University of Alabama at Birmingham (UAB) Comprehensive Diabetes Center have characterized a molecular tool that will allow researchers to further study long-term glucagon action and glucagon receptor signaling. 

UAB Comprehensive Diabetes Center Member and Division of Endocrinology, Diabetes, and Metabolism Associate Professor Anish Patel, M.D., recently sat down with UAB MedCast podcast to talk about the telehealth and diabetes.

UAB Comprehensive Diabetes Center Member and Division of Pediatric Endocrinology & Diabetes Assistant Professor Jessica Schmitt, M.D., recently sat down with UAB MedCast podcast to talk about treating pediatric patients with Type 1 diabetes.

Congressman Gary Palmer (AL-06) toured the UAB Comprehensive Diabetes Center (UCDC) on Wednesday, September 4, to learn more about the state of diabetes in Alabama.

Justin Alexander is the Lab Manager and a Researcher in the lab of Sushant Bhatnagar, Ph.D. He recieved his undergraduate degree from Auburn University.

UAB Comprehensive Diabetes Center Member and Division of Endocrinology, Diabetes, and Metabolism Assistant Professor Fernando Bril, M.D., recently sat down with UAB MedCast podcast to talk about metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes.

UAB Division of Endocrinology, Diabetes, and Metabolism Associate Professor and Scientist in the Comprehensive Diabetes Center Sushant Bhatnagar, Ph.D., was awarded a prestigious one-year R56 grant from the National Institutes of Health (NIH).

Sasanka Ramanadham, Ph.D., and collaborators, published an article entitled “Differential lipid signaling from CD4+ and CD8+ T cells contributes to Type 1 (T1D) diabetes development” in the peer-reviewed journal Frontiers in Immunology.

The scientific journal Frontiers in Endocrinology just published a peer-reviewed perspective article by UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., entitled “A novel class of oral, non-immunosuppressive, beta cell-targeting, TXNIP-inhibiting T1D drugs is emerging”. Other authors from the Shalev Lab include Gu Jing, Ph.D., and SeongHo Jo, Ph.D.

Ananda Basu, M.D., and researchers recently studied the difference in post-prandial glucose turnover between adolescents and adults with Type 1 diabetes (T1D).

UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., recently presented at the prestigious 2024 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium (Levine-Riggs Symposium), held in Pasadena, CA, which is organized by City of Hope^®, one of the leading research centers for diabetes and other life-threatening illnesses.

Sasanka Ramanadham, Ph.D., and researchers published “Selective Reduction of Ca2+-Independent Phospholipase A2β (iPLA2β)-Derived Lipid Signaling from Macrophages Mitigates Type 1 Diabetes Development"in the peer-reviewed journal Diabetes.

UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., has secured a $3 million National Institutes of Health (NIH) multi-PI R01 grant to study the effectiveness of TIX100, originally developed as an antidiabetic, in treating MASLD and MASH.

Many with Type 1 diabetes (T1D) know that exercising can be a bit tricky for the management of glucose. For instance, some types of physical activity might cause blood glucose to drop while engaging in other types of physical activity might not, and it can be difficult to anticipate blood glucose trends during exercise.

Fernando Bril, M.D., and colleagues recently investigated the relationship between insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD). 

Haifa "Saba" Alsharif, a fifth-year graduate student in Dr. Sushant Bhatnagar's Lab, was awarded a UAB Graduate Biomedical Sciences (GBS) award for mentorship at the 2024 symposium.

Fernando Ovalle, M.D., director of the UAB Division of Endocrinology, Diabetes, and Metabolism, and associate director of the UAB Comprehensive Diabetes Center (UCDC) recently published findings comparing insulin options for Type 1 diabetes (T1D) patients.

Sushant Bhatnagar, Ph.D., associate professor in the Division of Endocrinology, Diabetes, and Metabolism and scientist in the UAB Comprehensive Diabetes Center (UCDC) received pilot funding for his project “The role of brain angiogenesis inhibitor-3 GPCR signaling in adipose tissues.”